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Background
The RV144 trial has demonstrated a modest level of
protection against HIV infection, which was partially
related to binding antibodies targeting V2 loop. Along
with several broad HIV-neutralizing antibodies identified
recently, it is of great importance to understand the
major differences between vaccination and infection in
eliciting humoral immune responses.
Methods
We adopted a robust mapping technique for a quantita-
tive measurement of antigenic determinants of entire
SIVmac239 envelope glycoprotein displayed on the sur-
face of the yeast as a combinatorial antigen library. Posi-
tive yeast clones recognized by the immunized and/or
infected serum were identified and obtained by FACS
followed by sequencing and structural analysis.
Results
The finding of reactive determinants ranges from 30 to
240 amino acids, which allows some conformational deter-
minants being evaluated as a major technical improve-
ment. The antigen profile of the two types of vaccine-
induced sera before viral challenge shared two dominant
domains that concentrated at the V1V2 stem of gp120
and the ecto-domain of gp41. Interestingly, using a FACS-
based antibody binding assay, there were no significant dif-
ferences of titer and MFI of anti-V1V2 antibodies between
the two vaccination groups, suggested a minimal role of
these antibodies in controlling viral replication post
SIVmac239 challenge. A major distinct domain, however,
was identified near the V3 loop and the main CD4 binding
region which was significantly recognized by the immune
serum of the effective vaccination regimen but not of the
non-effective vaccination regimen or natural SIV infection.
Unexpectedly, the anti-V1/V2 antibody responses were
shifted to the ecto-gp41 region when infected macaques
developed AIDS.
Conclusion
We present a comprehensive analysis of antigenic deter-
minants recognized by specific antibody responses gener-
ated by vaccination and/or SIVmac239 infection. Our
findings have significant implications to help understand-
ing the humoral immunity against neutralization-resistant
SIVmac239 infection and simian AIDS, and to guide
rational vaccine immunogen identification and design.
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